References
- Hua Y, Guo X, Huang Q, et al. Association between interleukin-6 -174G/C polymorphism and the risk of Alzheimer's disease: a meta-analysis. Int J Neurosci 2013;123(9):626–35.
- Bhojak TJ, DeKosky ST, Ganguli M, Kamboh MI. Genetic polymorphisms in the cathespin D and interleukin-6 genes and the risk of Alzheimer's disease. Neurosci Lett 2000;288(1):21–4.
- Capurso C, Solfrizzi V, Colacicco AM, et al. Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 2010;34(1):177–82.
- Depboylu C, Lohmüller F, Gocke P, et al. An interleukin-6 promoter variant is not associated with an increased risk for Alzheimer's disease. Dement Geriatr Cogn Disord 2004;17(3):170–3.
- Bagli M, Papassotiropoulos A, Knapp M, et al. Association between an interleukin-6 promoter and 3’ flanking region haplotype and reduced Alzheimer's disease risk in a German population. Neurosci Lett 2000;283(2):109–12.
- Faltraco F, Bürger K, Zill P, et al. Interleukin-6-174 G/C promoter gene polymorphism C allele reduces Alzheimer's disease risk. J Am Geriatr Soc 2003;51(4):578–9.
- Shibata N, Ohnuma T, Takahashi T, et al. Effect of IL-6 polymorphism on risk of Alzheimer's disease: genotype-phenotype association study in Japanese cases. Am J Med Genet 2002;114(4):436–9.
- Cousin E, Macé S, Rocher C, et al. No replication of genetic association between candidate polymorphisms and Alzheimer's disease. Neurobiol Aging 2011;32(8):1443–51.
- Arosio B, Trabattoni D, Galimberti L, et al. Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease. Neurobiol Aging 2004;25(8):1009–15.
- Combarros O, Warden DR, Hammond N, et al. The dopamine β-hydroxylase-1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis Project. BMC Med Genet 2010;11:162.
- Klimkowicz-Mrowiec A, Wołkow P, Spisak K, et al. Interleukin-6 gene (-174 C/G) and apolipoprotein E gene polymorphisms and the risk of Alzheimer's disease in a Polish population. Neurol Neurochir Pol 2010;44(6):537–41.
- Shawkatová I, Javor J, Párnická Z, et al. No association between cytokine gene polymorphism and risk of Alzheimer's disease in Slovaks. Acta Neurobiol Exp 2010;70(3):303–7.
- Licastro F, Grimaldi LM, Bonafè M, et al. Interleukin-6 gene alleles affect the risk of Alzheimer's disease and levels of the cytokine in blood and brain. Neurobiol Aging 2003;24(7): 921–6.
- Pola R, Flex A, Gaetani E, et al. The -174 G/C polymorphism of the interleukin-6 gene promoter is associated with Alzheimer's disease in an Italian population. Neuroreport 2002;13(13):1645–7.
- He MX, Yang WL, Zhang MM, et al. Association between interleukin-6 gene promoter -572C/G polymorphism and the risk of sporadic Alzheimer's disease. Neurol Sci 2010;31(2):165–8.
- Wang M, Jia J. The interleukin-6 gene -572C/G promoter polymorphism modifies Alzheimer's risk in APOE epsilon 4 carriers. Neurosci Lett 2010;482(3):260–3.
- Capurso C, Solfrizzi V, D'Introno A, et al. Interleukin 6 -174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe. Exp Gerontol 2004;39(10):1567–73.